GT Biopharma, Inc. - 8-K Filing
GT Biopharma stockholders approve charter amendments to eliminate obsolete preferred stock and increase authorized common shares to 250 million. (Items: 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $GTBP
Read the full article at SEC EDGAR
Part of the story MARINEMAX INC - 8-K Filing (3 articles)